TrialX Updates: AI-Powered Trial Listings, Volunteer Outreach Enhancements, Patients as Partners Europe, and More…

Patients searching for clinical trials are often met with dense, technical language designed for scientific audiences, not for people trying to decide whether a study is right for them. If you’re part of a pharma, academic medical center, or patient advocacy organization looking to make trial information more accessible – we invite you to join us to explore how AI, guided by thoughtful prompt design, can turn technical listings into clear, patient-friendly summaries—without losing accuracy.


What We’re Hearing From the Field

“Across the industry, we’re hearing a clear shift in how sponsors are thinking about patient recruitment — moving away from broad, reactive outreach toward more precise, data-driven engagement. AI is playing a central role in that evolution, and at TrialX, we use AI to simplify both trial matching and content—making it easier for patients to understand eligibility and find studies that are right for them.
At the same time, a consistent challenge continues to surface: sponsors are often managing multiple vendors across recruitment, websites, and analytics, with limited visibility into what’s actually driving enrollment. AI is increasingly being looked at not just for patient identification, but for bringing greater transparency and control to the entire process. By unifying and continuously analyzing performance across channels, campaigns, and geographies, TrialX enables teams to optimize in real time.
The result is a more efficient, scalable approach to enrollment—with fewer fragmented vendors, greater operational control, and a single, end-to-end view of the patient journey. We explored this topic further in our recent webinar discussing – Designing Effective AI Prompts for Patient-Friendly Clinical Trial Listings! Register to watch the recording.”

Beth Dickson, VP, Business Development


What’s New at TrialX! 🚀

🤝 UPCOMING CONFERENCES

We will be in New Jersey at the 17th Annual Outsourcing in Clinical Trials East Coast conference, bringing together clinical operations leaders to discuss evolving strategies in trial execution and patient recruitment. If you’re attending, be sure to stop by TrialX Booth #2 and meet Beth Dickson, our VP, Business Development and Joshua McVoy, our Sales Development Representative.


We’re excited to participate in the Aerospace Medical Association (AsMA 2026), bringing together leaders in space medicine and human performance to explore health in extreme environments. In collaboration with the Translational Research Institute for Space Health (TRISH), TrialX will showcase its Space EHR system, designed to enable health data capture and research in remote and off-Earth settings. If you’re attending, stop by Booth #306 and meet our team.


This month, we’re excited to be in London for the Patients as Partners Europe conference as executive sponsors, and we look forward to connecting with you at Booth #3. Don’t miss our session on May 19 at 3:15 PM, where our Executive Chairman, Eric Sandor, will share best practices in patient recruitment technology—exploring how technology can empower patients to find the right clinical trials and how AI is shaping the future of patient engagement. You can also take a moment to recharge during a yoga break led by our Co-founder and CEO, Sharib Khan. If you’re attending, be sure to stop by and connect with our team!


❇️ PRODUCT HIGHLIGHTS

We are proud to support Montefiore Medical Center and the University of Cincinnati in building the FORETELL-Epilepsy app, an NIH-funded initiative to advance seizure forecasting and improve patient care. The app enables adults living with epilepsy to contribute real-world data through daily diaries of seizures, mood, and stress, and integrates with wearable devices to track heart rate and sleep. It is now live on app stores, with enrollment underway. We are glad and honored that the investigators and study team felt supported throughout the process, sharing: “I wanted to take a moment to express our sincere appreciation for the time and effort TrialX has dedicated to supporting us with the apps and troubleshooting whenever issues arise.” 


Recently, we introduced new enhancements to streamline our volunteer search and outreach. The improved interface enables more intuitive filtering with multi-select conditions and flexible location targeting, while saved searches allow teams to quickly reuse selection criteria. Users can now create volunteer lists for targeted outreach and track campaign performance with detailed engagement metrics, helping study teams identify, reach, and engage participants more efficiently. Learn More.


We supported a Top-5 pharma in successfully reaching their enrollment goal for a celiac disease clinical trial. By enabling engagement in 22 languages across 18 countries, and soon expanding to 40, we are proud to help sponsors and study teams run more inclusive trials and connect with the right participants in the right language, from local to global studies. Learn how we’re breaking down barriers to boost trial participation.


Space missions demand health monitoring in extreme, low-connectivity environments, where traditional tools often fall short. With more spaceflights on the horizon, including upcoming missions in NASA’s Artemis program, this need is only growing. TrialX Space Health Systems is an offline-capable, AI-powered platform designed to collect and analyze diverse health data—from wearables to genomics—even without connectivity, enabling research wherever the mission goes. In collaboration with the Translational Research Institute for Space Health (TRISH), we look forward to sharing more at the Aerospace Medical Association (AsMA) Annual MeetingLearn more.


📺 MEDIA & PRESS

Our Co-founder & CEO, Sharib Khan, was featured in Clinical Research News in the article “Space Health Research Could Rack Up Many Earthly Dividends.” The piece highlights how our space health research innovations – developed in collaboration with the Translational Research Institute for Space Health (TRISH), are enabling the collection of vital human health data from commercial spaceflights, with implications that extend beyond astronauts to advance clinical research on Earth. Read the full story.


RECENT CURETALKS 

Pancreatic cancer carries a high risk of recurrence even after surgery and chemotherapy, leaving patients with ongoing uncertainty. In this CureTalks session, Dr. Kim Reiss from Penn Medicine discusses advances in treatment, the role of genetic testing, and new approaches to reducing recurrence risk. She also shares insights on the Apollo trial, a study exploring targeted therapies for patients with surgically removed pancreatic cancer. Watch here.

🧬 FEATURED CLINICAL STUDIES 

Powered by TrialX

Caregiver Wellness Study (Remote): Caring for someone with Alzheimer’s can be exhausting—this study helps caregivers prioritize their own health. Participants will join a 6-month, fully virtual program with free exercise equipment, expert guidance, and ongoing support to reduce stress and improve well-being—all from home.

Oral Sugar Sensing Study: This in-person study at Monell Chemical Senses Center examines how hunger affects taste sensitivity to sugar. Participants will complete taste tests, glucose measurements, and surveys during a single study session and receive compensation for their time.

A Study to Investigate a New Treatment for COPD: This global study is evaluating a treatment targeting inflammation in individuals with COPD. Participants will undergo clinical assessments, lung function tests, and home monitoring to better understand treatment effectiveness compared to standard care.

Augmented Reality BCI Longitudinal Study for Late Stage ALS: This study evaluates an augmented reality brain-computer interface (BCI) to support communication in individuals with late-stage ALS. Participants will use the Cognixion Axon-R device over a 3-month period to assess usability, communication effectiveness, and AI-driven personalization.


🌎 AROUND THE WEB  

🌕 Organoids: Spaceflight is hard on the heart, yet artificial ones grow better in space.
🧠 AI drugs hit trials: New therapies designed using AI are entering human clinical testing. 
🫀 Ablation breakthrough: New clinical trial shows heart procedure outperforming medication for arrhythmia.
📊 Smarter trials emerge: Regulators explore AI to redesign early-phase clinical trials and speed decisions.


‼️ NOTEWORTHY

At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to simplify global patient recruitment management and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!

All the best,
Team TrialX

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
11

Get in touch to learn more about TrialX's Remote Data Collection Solutions

Request a Demo
30198

Shweta Mishra

Shweta is Marketing and Communications Lead at TrialX/Applied Informatics. She is a clinical trials enthusiast and also hosts women's health/infertility/reproductive medicine talk series driven by her personal experiences for TrialX CureTalks. A San Jose State University Graduate, she holds dual masters degree in Biochemistry and Nutrition Science, and is passionate about the science behind the diverse life phenomenon. She also holds certifications in Marketing Management & Strategy, Digital Marketing from Hubspot Academy, Protecting Human Research Participants from NIH and in Intellectual Property in Biotechnology from WIPO.